New Delhi: Bharat Biotech said on Wednesday that a booster dose of COVAXIN® (BBV152) produced strong neutralizing antibody responses against both omicron and delta forms of SARS-CoV-2.
Bharat Biotech said that 100 percent of the tested serum samples showed neutralization of the delta variant and more than 90 percent of the serum samples showed neutralization. omicron Type.
The Covaxin manufacturer said in an announcement on Twitter, “These data add to the body of evidence that the broad-spectrum mechanism of action of a whole virus inactivated COVID-19 vaccine, like COVAXIN, is a viable option in this ever-evolving pandemic.” ” ,
Earlier in the day, the Union Health Ministry reported that with the administration of more than 85,26,240 vaccine doses in the last 24 hours, the country’s cumulative COVID-19 vaccination coverage has exceeded 153.80 crore.
The Health Ministry said that this has been achieved through 1,64,73,522 sessions.
The Health Ministry also informed that 60,405 patients have been cured in the last 24 hours and the total number of patients who have been cured since the beginning of the Kovid-19 epidemic is 3,46,30,536.
“As a result, India’s recovery rate is 96.01%,” the ministry said.
The Health Ministry said that a total of 1,94,000 new cases were reported in the last 24 hours.
“India’s active caseload currently stands at 9,55,319. Active cases account for 2.65% of the total positive cases in the country,” the ministry said.
Stating that the testing capacity has been ramped up across the country, the Health Ministry said: “The weekly positivity rate in the country is currently 9.82% and the daily positivity rate is also reported to be 11.05%.”
See below health equipment-
Calculate your body mass index (BMI)
,